A polymorphism at the miR-502 binding site in the 3 '-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome
机构:[1]Department of Gastroenterology and Hepatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China临床科室消化内科河北医科大学第四医院[2]Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China医技科室病理科河北医科大学第四医院[3]Department of Gynaecology Ultrasound, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China医技科室妇产超声科河北医科大学第四医院[4]Hebei Key Lab of Laboratory Animal Science, Hebei Medical University, Shijiazhuang, People’s Republic of China[5]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China河北医科大学第四医院院领导行政科室
MicroRNAs (miRNAs) can bind to the 3'-untranslated regions (UTRs) of messenger RNAs, where they interfere with translation and thereby regulate cell differentiation, apoptosis and tumorigenesis. Genetic polymorphisms in the 3'-UTRs targeted by miRNAs alter the strength of miRNA binding in a manner that affects the behavior of individual miRNAs. The histone methyltransferase SET8 has been reported to methylate TP53 and regulate genomic stability. We analyzed a single-nucleotide polymorphism (rs16917496) within the miR-502 miRNA seed region for the 3'-UTR of SET8 in Chinese patients with hepatocellular carcinoma (HCC). The SET8 CC genotype was independently associated with longer postoperative survival in patients with HCC by multivariate analysis (relative risk, 0.175; 95% CI = 0.0530.577; p = 0.004). The SET8 CC genotype was associated with reduced SET8 protein levels based on the immunostaining of 51 HCC tissue samples. We also found that the low SET8 levels were associated with longer HCC survival. Our data suggest that SET8 modifies HCC outcome by altering its expression, which depends, at least in part, on its binding affinity with miR-502. The analysis of genetic polymorphisms in miRNA binding sites can help to identify patient subgroups that are at high risk for poor disease outcomes.
基金:
National Natural Science Foundation of People's Republic of ChinaNational Natural Science Foundation of China (NSFC) [30801384]; Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [C2008000958]
第一作者机构:[1]Department of Gastroenterology and Hepatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[5]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China[*1]Research Center,The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang 050011, People’s Republic of China
推荐引用方式(GB/T 7714):
Guo Zhanjun,Wu Chensi,Wang Xiaoling,et al.A polymorphism at the miR-502 binding site in the 3 '-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome[J].INTERNATIONAL JOURNAL OF CANCER.2012,131(6):1318-1322.doi:10.1002/ijc.27352.
APA:
Guo, Zhanjun,Wu, Chensi,Wang, Xiaoling,Wang, Cuiju,Zhang, Ruixing&Shan, Baoen.(2012).A polymorphism at the miR-502 binding site in the 3 '-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome.INTERNATIONAL JOURNAL OF CANCER,131,(6)
MLA:
Guo, Zhanjun,et al."A polymorphism at the miR-502 binding site in the 3 '-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome".INTERNATIONAL JOURNAL OF CANCER 131..6(2012):1318-1322